BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27154064)

  • 1. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.
    Klement RJ; Sonke JJ; Allgäuer M; Andratschke N; Appold S; Belderbos J; Belka C; Dieckmann K; Eich HT; Flentje M; Grills I; Eble M; Hope A; Grosu AL; Semrau S; Sweeney RA; Hörner-Rieber J; Werner-Wasik M; Engenhart-Cabillic R; Ye H; Guckenberger M
    Radiother Oncol; 2020 Jan; 142():210-216. PubMed ID: 31431371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
    Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
    [No Abstract]   [Full Text] [Related]  

  • 6. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.
    Gay HA; Sibata CH; Allison RR; Jeremic B
    Radiother Oncol; 2009 Jun; 91(3):369-78. PubMed ID: 19058867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of indirect damage and damage saturation effects in dose-response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases.
    Gago-Arias A; Neira S; Pombar M; Gómez-Caamaño A; Pardo-Montero J
    Radiother Oncol; 2021 Aug; 161():1-8. PubMed ID: 34015386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
    Chan MKH; Chiang CL
    Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
    Lu JY; Lin Z; Lin PX; Huang BT
    J Cancer; 2019; 10(19):4655-4661. PubMed ID: 31528230
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer.
    Paz AE; Yamamoto N; Sakama M; Matsufuji N; Kanai T
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1551-1559. PubMed ID: 30076985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
    Astrahan M
    Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
    Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
    Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A challenge to traditional radiation oncology.
    Fowler JF; Tomé WA; Fenwick JD; Mehta MP
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1241-56. PubMed ID: 15519797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.
    Shultz DB; Trakul N; Maxim PG; Diehn M; Loo BW
    Pract Radiat Oncol; 2014; 4(4):272-8. PubMed ID: 25012837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.